These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29307549)

  • 1. Favorable effects of statins in the treatment of heart failure with preserved ejection fraction in patients without ischemic heart disease.
    Tsujimoto T; Kajio H
    Int J Cardiol; 2018 Mar; 255():111-117. PubMed ID: 29307549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Effects of Statin Use on Mortality in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
    Lee MS; Duan L; Clare R; Hekimian A; Spencer H; Chen W
    Am J Cardiol; 2018 Aug; 122(3):405-412. PubMed ID: 30201108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry.
    Alehagen U; Benson L; Edner M; Dahlström U; Lund LH
    Circ Heart Fail; 2015 Mar; 8(2):252-60. PubMed ID: 25575580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low diastolic blood pressure and adverse outcomes in heart failure with preserved ejection fraction.
    Tsujimoto T; Kajio H
    Int J Cardiol; 2018 Jul; 263():69-74. PubMed ID: 29661477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of renin-angiotensin system inhibitors for patients with heart failure with preserved ejection fraction and mild to moderate chronic kidney disease.
    Tsujimoto T; Kajio H
    Eur J Prev Cardiol; 2018 Aug; 25(12):1268-1277. PubMed ID: 29808753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Use of Statins and Mortality in Patients With Heart Failure and Ejection Fraction of ≥50.
    Alehagen U; Benson L; Edner M; Dahlström U; Lund LH
    Circ Heart Fail; 2015 Sep; 8(5):862-70. PubMed ID: 26243795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Statins on Mortality in Heart Failure With Preserved Ejection Fraction Without Coronary Artery Disease　- Report From the JASPER Study.
    Marume K; Takashio S; Nagai T; Tsujita K; Saito Y; Yoshikawa T; Anzai T
    Circ J; 2019 Jan; 83(2):357-367. PubMed ID: 30416189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate and the risk of adverse outcomes in patients with heart failure with preserved ejection fraction.
    O'Neal WT; Sandesara PB; Samman-Tahhan A; Kelli HM; Hammadah M; Soliman EZ
    Eur J Prev Cardiol; 2017 Jul; 24(11):1212-1219. PubMed ID: 28482692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of statins on mortality in heart failure with preserved ejection fraction: a meta-analysis of propensity score analyses.
    Fukuta H; Goto T; Wakami K; Ohte N
    Int J Cardiol; 2016 Jul; 214():301-6. PubMed ID: 27082778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of statin use in patients with heart failure and preserved ejection fraction.
    Nochioka K; Sakata Y; Miyata S; Miura M; Takada T; Tadaki S; Ushigome R; Yamauchi T; Takahashi J; Shimokawa H;
    Circ J; 2015; 79(3):574-82. PubMed ID: 25746542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist).
    Hegde SM; Claggett B; Shah AM; Lewis EF; Anand I; Shah SJ; Sweitzer NK; Fang JC; Pitt B; Pfeffer MA; Solomon SD
    Circulation; 2017 Sep; 136(11):982-992. PubMed ID: 28637881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF.
    Tsujimoto T; Kajio H
    J Am Coll Cardiol; 2017 Dec; 70(22):2739-2749. PubMed ID: 29191321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study.
    Vedin O; Lam CSP; Koh AS; Benson L; Teng THK; Tay WT; Braun OÖ; Savarese G; Dahlström U; Lund LH
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28615366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diastolic Blood Pressure and Adverse Outcomes in the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) Trial.
    Sandesara PB; O'Neal WT; Kelli HM; Topel M; Samman-Tahhan A; Sperling LS
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Ischemic Heart Disease in Major Adverse Renal and Cardiac Events Among Individuals With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial).
    Rahimi G; Tecson KM; Elsaid O; McCullough PA
    Am J Cardiol; 2021 Mar; 142():91-96. PubMed ID: 33279481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perturbations in serum chloride homeostasis in heart failure with preserved ejection fraction: insights from TOPCAT.
    Grodin JL; Testani JM; Pandey A; Sambandam K; Drazner MH; Fang JC; Tang WHW
    Eur J Heart Fail; 2018 Oct; 20(10):1436-1443. PubMed ID: 29893446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy and clinical outcomes in heart failure: a propensity-matched analysis.
    Ouzounian M; Tu JV; Austin PC; Chong A; Liu PP; Lee DS
    J Card Fail; 2009 Apr; 15(3):241-8. PubMed ID: 19327626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.